Dr. Laura M. Dember, MD

Dr. Dember practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Dember's NPI, 1144285370, was assigned on April 19, 2006. Dr. Dember graduated from Yale University School of Medicine in 1988. Dr. Dember holds Pennsylvania license MD043271L.

Dr. Dember's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Dember's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Dember is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Dember to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dember practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Dember's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Dember is licensed in Pennsylvania.

CMS data shows 171 Medicare services from Dr. Dember across 4 procedure codes in 2024, for 62 Medicare patients. Medicare paid $7,161 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 62 Medicare patients who saw Dr. Dember in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 4.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dember's median patient age at 63, with 50% women.

In 2024, Dr. Dember wrote 214 Medicare Part D claims for 30 patients. 91% of them were for generic drugs. CMS names the drug for 81 of them, across 4 drugs with 11 or more claims each, at $2,217 in total drug cost. In 2023, CMS named 94 claims across 4 drugs.

Dr. Dember accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dember as offering telehealth.

Dmand AI links 43 papers to Dr. Dember, published from 2019 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Renal Dialysis, Kidney Failure, Chronic and Randomized Controlled Trials as Topic. Dr. Dember has published most often in Am J Kidney Dis. Dr. Dember's most frequent co-authors are Manisha Jhamb, Sarah Jeanne Schrauben, MD and Talat A. Ikizler, MD.

CMS Open Payments shows 51 general payments to Dr. Dember from 6 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 98% of the total. Vertex Pharmaceuticals Incorporated paid the most, $53,815. It also lists 1 research payment totaling $259,896 in 2016.

Dr. Dember graduated from Yale University School of Medicine in 1988.